Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RegeneRx Biopharmaceuticals Inc.

www.regenerx.com

Latest From RegeneRx Biopharmaceuticals Inc.

Deal Watch, Focus On Acquisitions: Emergent Acquires PaxVax, Pair Of Commercialized Vaccines

Emergent gets vaccines for cholera and typhoid fever in PaxVax buyout. By taking over the OvaScience shell to go public, Millendo expects to take lead candidate livelotide into a pivotal study early next year.

Deals M & A

FDA Tells RegeneRx It Needs 3rd Phase III Trial On RGN-259 For Dry Eye Syndrome

The FDA is requiring an additional RGN-259 Phase III trial to further show efficacy in both signs and symptoms of dry eye in a larger patient population.

Analysis Approvals

Mixed Results From ReGenTree's DES Therapy In Second Phase III

ReGenTree has reported mixed results in its second pivotal Phase III trial of RGN-259 indicating that the therapy is most effective in patients with severe dry eye. The results raise some doubts about the treatment’s potential approval for the general dry eye population.

Research & Development Clinical Trials

Novartis Hopes Lubris In-Licensing Deal Will Lead To Dry Eye Solution

ON the lookout for potential ophthalmology options despite recent setbacks in the area, Novartis has now spotted ECF843, an investigative recombinant human lubricin – or natural lubricant – for dry eye.

Commercial Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cardiovascular
  • Dermatology
  • Neurology, Nervous System
  • Ophthalmic
  • Alias(es)
  • Alpha 1 Biomedicals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • RegeneRx Biopharmaceuticals Inc.
  • Senior Management
  • J.J. Finkelstein, Pres. & CEO
    Dane Saglio, CFO
    Alan Klein, CBO
  • Contact Info
  • RegeneRx Biopharmaceuticals Inc.
    Phone: (301) 208-9191
    15245 Shady Grove Rd.
    Ste. 470
    Rockville, MD 20850
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register